logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Julie Yamaguchi

This inventor holds 10 USPTO granted patents and 3 EPO patents. Top assignee: Abbott Laboratories Corporation. Active years: 1997-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie Yamaguchi. Retrieved from https://idiyas.com/inventor/julie-yamaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 40.0

 

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 52(Granted Patents)


Company Filing History:

goldMedal10 out of 4,187 
 
Abbott Laboratories Corporation
 patents

Years Active: 1997-2015

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9150834 - Human immunodeficiency virus and uses thereof (2015-10-06),
2. 8785596 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2014-07-22),
3. 7883845 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2011-02-08),
4. 7619061 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-17),
5. 7615614 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-10),
6. 7615613 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2009-11-10),
7. 6846905 - Antigen constructs useful in the detection and differentiation of antibodies to HIV (2005-01-25),
8. 5854001 - Hepatitis C virus fusion proteins (1998-12-29),
9. 5667992 - Mammalian expression systems for HCV proteins (1997-09-16),
10. 5610009 - Mammalian expression systems for hepatitis C virus envelope genes (1997-03-11),

Title: Julie Yamaguchi: Innovator in HIV Research

Introduction

Julie Yamaguchi is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of HIV research. With a total of 10 patents to her name, she has made remarkable strides in developing innovative solutions for the detection and treatment of Human Immunodeficiency Virus (HIV).

Latest Patents

Her latest patents include groundbreaking inventions related to Human Immunodeficiency Virus-1 (HIV-1) Group P. One of her notable inventions focuses on the detection of HIV-1 Group P and its fragments, which are essential for creating immunoassays and nucleic acid-based assays. Additionally, she has developed antigen constructs that are useful in the detection and differentiation of antibodies to HIV, utilizing isolated HIV-1 Group O env polypeptides and various antigen constructs.

Career Highlights

Julie Yamaguchi has built a successful career at Abbott Laboratories Corporation, where she continues to innovate in the field of medical research. Her work has not only advanced scientific understanding but has also contributed to the development of therapeutic compositions for HIV.

Collaborations

Throughout her career, Yamaguchi has collaborated with esteemed colleagues, including Sushil G Devare and Catherine A Brennan, further enhancing the impact of her research.

Conclusion

Julie Yamaguchi's contributions to HIV research exemplify her dedication to innovation and her commitment to improving public health. Her patents and ongoing work at Abbott Laboratories Corporation continue to pave the way for advancements in the detection and treatment of HIV.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…